Here we report on the synthesis, antibody binding, and QSAR studies of a series of linear and cyclic peptides containing a β-amyloid plaque-specific epitope (Aβ(4 10); FRHDSGY). In these constructs, two or three α-l-Ala, α-d-Ala, or β-Ala residues were introduced at both N- and C-termini of the epitope as non-native flanking sequences. Cyclization of the linear Aβ(4 10) epitope peptide resulted in reduced antibody binding. However, the antibody binding could be fully compensated by insertion of alanine flanks into the corresponding cyclic peptides. These results indicate that the modification of a β-amyloid plaque-specific epitope by combination of cyclization and flanking sequences could generate highly antigenic peptides compared to the n...
Alzheimer's disease (AD), is the most common neurodegenerative disorder of the aging population resu...
The engineering of antigenic determinants on super secondary structures using de novo design approac...
Alzheimer's disease (AD) is the most common form of dementia. Amyloid-beta (A beta) peptide, generat...
Here we report on the synthesis, antibody binding, and QSAR studies of a series of linear and cyclic...
Antibodies against Aß amyloid are indispensable research tools and potential therapeutics for Alzhei...
Which conformational parameters lead to an antibody-affine peptide antigen? And in how many differen...
<div><p>Which conformational parameters lead to an antibody-affine peptide antigen? And in how many ...
There is great interest in drug discovery programs targeted at the aggregation of the 42-residue for...
Amyloid aggregates of the amyloid-{beta} (A{beta}) peptide are implicated in the pathology of Alzhei...
Amyloid plaques (AP) represent one of the main molecular hallmarks of Alzheimer's disease (AD). In o...
ABSTRACT: â-Amyloid (Aâ), the primary protein component of Alzheimer’s plaques, is neurotoxic when a...
Amyloid plaques are the main molecular hallmark of Alzheimer's disease. Specific carriers are needed...
Oligomeric amyloid β (Aβ) is currently considered the most neurotoxic form of the Aβ peptide implica...
The strong intermolecular interactions mediated by short hydrophobic sequences (e.g., 17-20, -L-Leu-...
The strong intermolecular interactions mediated by short hydrophobic sequences (e.g., 17-20, -L-Leu-...
Alzheimer's disease (AD), is the most common neurodegenerative disorder of the aging population resu...
The engineering of antigenic determinants on super secondary structures using de novo design approac...
Alzheimer's disease (AD) is the most common form of dementia. Amyloid-beta (A beta) peptide, generat...
Here we report on the synthesis, antibody binding, and QSAR studies of a series of linear and cyclic...
Antibodies against Aß amyloid are indispensable research tools and potential therapeutics for Alzhei...
Which conformational parameters lead to an antibody-affine peptide antigen? And in how many differen...
<div><p>Which conformational parameters lead to an antibody-affine peptide antigen? And in how many ...
There is great interest in drug discovery programs targeted at the aggregation of the 42-residue for...
Amyloid aggregates of the amyloid-{beta} (A{beta}) peptide are implicated in the pathology of Alzhei...
Amyloid plaques (AP) represent one of the main molecular hallmarks of Alzheimer's disease (AD). In o...
ABSTRACT: â-Amyloid (Aâ), the primary protein component of Alzheimer’s plaques, is neurotoxic when a...
Amyloid plaques are the main molecular hallmark of Alzheimer's disease. Specific carriers are needed...
Oligomeric amyloid β (Aβ) is currently considered the most neurotoxic form of the Aβ peptide implica...
The strong intermolecular interactions mediated by short hydrophobic sequences (e.g., 17-20, -L-Leu-...
The strong intermolecular interactions mediated by short hydrophobic sequences (e.g., 17-20, -L-Leu-...
Alzheimer's disease (AD), is the most common neurodegenerative disorder of the aging population resu...
The engineering of antigenic determinants on super secondary structures using de novo design approac...
Alzheimer's disease (AD) is the most common form of dementia. Amyloid-beta (A beta) peptide, generat...